Skip main navigation

Investor Information
Investor Information

Home > Investor Information > Financial Highlights > Sales of Major Products

Skip side navigation

Main contents starts here

Sales of Major Products

Worldwide Sales of International Strategic Products (Region and Consolidated basis)

(Billions of Yen)
  FY2005 FY2006 FY2007 FY2008 FY2009
Leuprorelin 122.4 127.5 124.0 126.1 122.2
  Japan (unconsolidated) 63.2 64.3 66.4 66.3 67.1
Americas 19.7 21.1 14.1 17.2 15.8
Europe 37.1 39.5 40.2 39.8 36.2
Asia 2.4 2.7 3.3 2.8 3.1
Lansoprazole 159.9 150.7 148.7 271.4 218.1
  Japan (unconsolidated) 55.0 57.9 64.8 70.7 74.3
Americas 57.3 50.2 45.2 173.1 119.0
Europe 44.9 39.5 35.6 24.3 21.2
Asia 2.6 3.1 3.1 3.2 3.7
Candesartan 190.9 206.2 223.1 230.3 222.0
  Japan (unconsolidated) 123.5 129.3 137.1 137.9 136.2
Americas, Europe, Asia 67.4 76.9 86.0 92.5 85.8
Pioglitazone 243.8 336.3 396.2 387.0 384.7
  Japan (unconsolidated) 24.2 33.7 41.6 48.8 52.7
Americas 202.2 277.3 318.6 301.7 297.4
Europe 15.5 22.7 32.5 32.8 31.2
Asia 1.9 2.7 3.4 3.7 3.5

[*] Worldwide sales of Candesartan are divided into only two segments, because exports sales of this product to a licensee are recorded under a single route.


Domestic Sales of Ethical Drugs (Top 10 ranking)

(Billions of Yen)
Ranking Product Therapeutic Class FY
2006
FY
2007
FY
2008
FY
2009
1 Blopress Hypertensions 129.3 137.1 137.9 136.2
2 Takepron Peptic ulcers 57.9 64.8 70.7 74.3
3 Leuplin Prostate cancer, breast cancer and endometriosis 64.3 66.4 66.3 67.1
4 Actos Diabetes 33.7 41.6 48.8 52.7
5 Basen Diabetes 55.7 52.8 47.1 43.0
6 Enbrel Rheumatoid arthritis 11.4 18.8 26.3 32.3
7 Benet Osteoprosis 16.2 16.5 16.3 17.9
8 Seltouch Topical NSAID 12.7 12.3 11.3 10.5
9 Glovenin Immuno-globulin 8.6 8.8 9.3 10.3
10 Rheumatrex Rheumatoid arthritis 6.9 7.7 8.5 9.0

Sales of Consumer Healthcare Major Items

(Billions of Yen)
Ranking   FY2006 FY2007 FY2008 FY2009
1 Alinamin A & EX 14.6 15.1 14.6 14.6
2 Alinamin V/V&V/7 12.1 12.3 12.8 12.2
3 Benza 7.7 8.4 8.5 7.8
4 Biofermin 6.4 7.1 7.1 6.6
5 Nicorette 4.3 4.2 4.4 4.0

Stock Performance

TSE 7/30 15:00

Last
3,965
Change
-15

Related Links

Page Top